Go Pro
LON:BIOG

The Biotech Growth Trust (BIOG) Share Price, News & Analysis

The Biotech Growth Trust logo
GBX 1,622 -6.00 (-0.37%)
As of 09/11/2026 12:15 PM Eastern

About The Biotech Growth Trust Stock (LON:BIOG)

Advanced

Key Stats

Today's Range
1,592
1,622
50-Day Range
1,556
1,772.02
52-Week Range
912
1,786
Volume
218,036 shs
Average Volume
80,454 shs
Market Capitalization
£307.95 million
P/E Ratio
2.91
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

Receive BIOG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for The Biotech Growth Trust and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BIOG Stock News Headlines

The Biotech Growth Trust PLC - Net Asset Value(s)
Trump and Bernie agree on this
Donald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.tc pixel
The Biotech Growth Trust PLC - Annual Financial Report
See More Headlines

BIOG Stock Analysis - Frequently Asked Questions

The Biotech Growth Trust's stock was trading at GBX 1,200 on January 1st, 2026. Since then, BIOG shares have increased by 35.2% and is now trading at GBX 1,622.

The Biotech Growth Trust PLC (LON:BIOG) released its earnings results on Wednesday, June, 3rd. The company reported ($1.90) earnings per share (EPS) for the quarter. The firm had revenue of $0.43 million for the quarter. The Biotech Growth Trust had a net margin of 96.47% and a trailing twelve-month return on equity of 48.26%.

Shares of BIOG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that The Biotech Growth Trust investors own include Polar Capital Technology Trust (PCT), Guild Esports (GILD), National Grid (NG.L), Solid Biosciences (SLDB), Scottish Mortgage (SMT), Touchstone Exploration (TXP) and Wheaton Precious Metals (WPM).

Company Calendar

Last Earnings
6/03/2026
Today
9/12/2026

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Finance
Industry
Capital Markets
Sub-Industry
Asset Management & Custody Banks
Current Symbol
LON:BIOG
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 558
Trailing P/E Ratio
2.91
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£83.83 million
Net Margins
96.47%
Pretax Margin
N/A
Return on Equity
48.26%
Return on Assets
12.39%

Debt

Debt-to-Equity Ratio
4.37
Current Ratio
0.89
Quick Ratio
0.00

Sales & Book Value

Annual Sales
£133.86 million
Price / Sales
2.30
Cash Flow
GBX 18.49 per share
Price / Cash Flow
87.74
Book Value
GBX 1,077.42 per share
Price / Book
1.51

Miscellaneous

Outstanding Shares
18,986,000
Free Float
N/A
Market Cap
£307.95 million
Optionable
Not Optionable
Beta
0.58
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (LON:BIOG) was last updated on 9/12/2026 by MarketBeat.com Staff.
From Our Partners